Scandion Oncology A/S
Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.
SCOL | ST
Overview
Corporate Details
- ISIN(s):
- DK0061031895 (+3 more)
- LEI:
- 549300MPWDMQ5LZEGD09
- Country:
- Denmark
- Address:
- Fruebjergvej 3, 2100 København Ø
- Website:
- https://scandiononcology.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Scandion Oncology A/S is a biotechnology company currently under liquidation. Previously, it operated as a clinical-stage company focused on developing first-in-class medicines to overcome cancer drug resistance. The company's primary mission was to revert resistance to existing anti-cancer therapies. Its lead compound, SCO-101, was being developed as an oral, add-on drug for use in combination with standard chemotherapy to improve treatment efficacy for cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Scandion Oncology A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Scandion Oncology A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
